Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Provention Bio, Inc. (PRVB)
|
|
| Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 |
| | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues | 100.0% | | | | |
| Cost of goods sold | 0.0% | | | | |
| Gross profit | 100.0% | | | | |
| Research and development | 4991.2% | | | | |
| General and administrative | 3394.0% | | | | |
| EBITDA | -8257.4% | | | | |
| Depreciation | 27.7% | | | | |
| EBIT | -8285.2% | | | | |
| Pre-tax income | -8274.7% | | | | |
| Income taxes | -71.7% | | | | |
| Net income | -8203.0% | | | | |
|